Skip to search.
 FTSE 100 Up 0.42%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
369.15 Up 7.14(1.97%) 21:00
|After Hours: : 368.90 Down 0.25 (0.07%) 23:15 - Nasdaq Real Time Price
Prev Close:362.01
Open:361.80
Bid:346.68 x 100
Ask:377.74 x 100
1y Target Est:450.71
Beta:1.54217
Earnings Date:7 Feb - 13 Feb (Est.)
Day's Range:359.50 - 370.49
52wk Range:325.35 - 563.79
Volume:972,970
Avg Vol (3m):863,992
Market Cap:39.61b
P/E (ttm):53.86
EPS (ttm):6.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 1.97%39.61b
AMGNDown 0.42%104.59b
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):25.83
P/S (ttm):8.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.76
Quarterly EPS Est (Dec-16) :3.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback